Did studies on HFOV fail to improve ARDS survival because they did not decrease VILI? On the potential validity of a...

Area of Science:

• Critical Care Medicine
• Respiratory Physiology
• Mechanical Ventilation

Background:

• High frequency oscillatory ventilation (HFOV) has been debated for acute respiratory distress syndrome (ARDS) treatment for decades.
• Despite physiological rationale, recent trials question HFOV's efficacy in ARDS.
• Concerns exist regarding potential harm and increased mortality associated with HFOV.

Purpose of the Study:

• To re-examine the physiological basis of HFOV in ARDS.
• To evaluate the impact of HFOV on mortality in adult ARDS patients.
• To contrast HFOV's outcomes with alternative ARDS management strategies.

Main Methods:

• Review of physiological research on HFOV.
• Analysis of data from two high-quality randomized clinical trials in adult ARDS patients.
• Comparison of HFOV outcomes with interventions like tidal volume reduction, paralysis, and prone positioning.

Main Results:

• Two major randomized trials demonstrated that HFOV did not decrease, and potentially increased, mortality in ARDS.
• The physiological concepts of atelectrauma and biotrauma underpinning HFOV require reevaluation.
• Volutrauma, or lung overdistension, may explain excess mortality in ARDS patients ventilated with high tidal volumes.

Conclusions:

• HFOV is not associated with improved survival in ARDS and may be detrimental.
• The effectiveness of simpler ARDS interventions (low tidal volume, paralysis, prone positioning) highlights the importance of limiting end-inspiratory lung volume.
• Revisiting the mechanisms of ventilator-induced lung injury, particularly volutrauma, is crucial for optimizing ARDS management.